Cue Biopharma Presents 'Positive' Update From Phase 1 Trials of CUE-101, CUE-102

TipRanks13:45 ET

Express News | Cue Biopharma Presents Positive Updated Data From Its Phase 1 Trials of Cue-101 and Cue-102 in Head and Neck Cancer and Wt1 Positive Cancers at the SITC 39TH Annual Meeting

Reuters13:30 ET

Cue Biopharma (NASDAQ:CUE) Adds US$31m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 89%

Yahoo FinanceOct 8 06:13 ET

12 Health Care Stocks Moving In Monday's Intraday Session

BenzingaOct 7 12:31 ET

Trevena TRVN -58% AH NASDAQ Delisting; Cue Biopharma CUE +42% SITC Presentation

BioPharmCatalystOct 4 16:26 ET

Express News | Cue Biopharma Inc: Second Amendment Removes Requirement for Co to Maintain in Accounts of Svb Cash Equal to at Least $20 Mln

ReutersOct 4 16:04 ET